Review for 10.1186/s12876-020-01399-5 (2020)

Reviewer ’s report  
 
Title: A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid  
ursodeoxycholic manufactured by the university hospital for t he treatment of primary biliary  
cholangitis  
 
Version: 1 Date: 12 Jun 2020  
 
Reviewer's report:  
 
Please include all comments for the authors in this box rather than uploading your report as an 
attachment. P lease only upload as attachments annotated versions of manuscripts, graphs, 
supporting materials or other aspects of your report which cannot be included in a text format.  
Please overwrite this text when adding your comments to the authors.  
 
The revised ma nuscript is suitable for publication  
 
Are the methods appropriate and well described?  
If not, please specify what is required in your comments to the authors.  
 
Yes 
 
Does the work include the necessary controls?  
If not, please specify which controls are requir ed in your comments to the authors.  
 
Yes 
 
Are the conclusions drawn adequately supported by the data shown?  
If not, please explain in your comments to the authors.  
 
Yes 
 
Are you able to assess any statistics in the manuscript or would you recommend an  
additional statistical review?  
If an additional statistical review is recommended, please specify what aspects require further  
assessment in your comments to the editors.  
 
I am able to assess the statistics  
 
Quality of written English  
Please indicate the qua lity of language in the manuscript:  
 
Acceptable  
 
 
 
Declaration of competing interests  
Please complete a declaration of competing interests, considering the following questions:  
 
1. Have you in the past five years received reimbursements, fees, funding, or salar y from an  
organisation that may in any way gain or lose financially from the publication of this  
manuscript, either now or in the future?  
 
2. Do you hold any stocks or shares in an organisation that may in any way gain or lose  
financially from the publicati on of this manuscript, either now or in the future?  
 
3. Do you hold or are you currently applying for any patents relating to the content of the  
manuscript?  
 
4. Have you received reimbursements, fees, funding, or salary from an organization that 
holds  or has  applied for patents relating to the content of the manuscript?  
 
5. Do you have any other financial competing interests?  
 
6. Do you have any non -financial competing interests in relation to this paper?  
 
If you can answer no to all of the above, write 'I decla re that I have no competing interests' 
below.  If your reply is yes to any, please give details below.  
 
'I declare that I have no competing interests  
 
Reviewer Publication Consent. I agree for my report to be made available under an Open 
Access  Creative Commo ns CC -BY License ( http://creativecommons.org/licenses/by/4.0 ) if this 
manuscript  is accepted for publication. Any comments that I do not wish to be included in the 
published  report have been included as confidential comments to the editor, which will not be 
published.  If you are not happy for us to publish this report, please contact the editorial office 
before completing  the review.  If you wish, you can include your name in you r published report. 
Please note you must  decide whether to include your name at the start of the process and confirm 
this decision whenever  prompted. If you change your decision later, we will not be able to 
publish your name.  
 
I agree to the terms of the C C-BY 4.0 license; please do not publish my name with my report.  
(default)  
 
 
 
 
 
 
 
 
Publons Reviewer Recognition . Springer Nature can send verification of this review directly to  
Publons (a subsidiary of Clarivate Analytics). If you would like to take advantage of t his service,  
please click on the “Yes” option below. Your name, email address, title of the reviewed  
manuscript, name of the journal, and date of your review submission (the “Review Data ”) will  
then be transmitted to Publons upon publication of the manuscr ipt. If you have already registered  
at Publons, they will notify you of the receipt of this review and update your profile as per your  
settings and their policy. If you are not registered with Publons, you will receive an email from  
them asking you to regi ster in order for them to be able to recognize your review on your new  
profile page. Publons may use the Review Data to generate derivative metadata for the benefit of  
Publons and you as a reviewer, carefully considering the sensitivity of such information . For  
example, Publons may verify your record as a reviewer by updating your profile published on its  
webservice if you have registered for such service or help editors to identify candidate reviewers.  
Please find the details of processing in Publons ’ privacy policy https://publons.com/about/terms  
 
Yes